ANI Pharmaceuticals Statistics Share Statistics ANI Pharmaceuticals has 21.65M
shares outstanding. The number of shares has increased by 2.95%
in one year.
Shares Outstanding 21.65M Shares Change (YoY) 2.95% Shares Change (QoQ) -0.51% Owned by Institutions (%) 99.99% Shares Floating 18.02M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.13M, so 9.82% of the outstanding
shares have been sold short.
Short Interest 2.13M Short % of Shares Out 9.82% Short % of Float 12.34% Short Ratio (days to cover) 8.46
Valuation Ratios The PE ratio is -57.66 and the forward
PE ratio is 11.69.
ANI Pharmaceuticals's PEG ratio is
0.3.
PE Ratio -57.66 Forward PE 11.69 PS Ratio 1.74 Forward PS 2.1 PB Ratio 2.49 P/FCF Ratio 22.69 PEG Ratio 0.3
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ANI Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.72,
with a Debt / Equity ratio of 1.46.
Current Ratio 2.72 Quick Ratio 2.02 Debt / Equity 1.46 Debt / EBITDA 7.89 Debt / FCF 13.26 Interest Coverage 0.03
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $684.92K Profits Per Employee $-20.65K Employee Count 897 Asset Turnover 0.48 Inventory Turnover 1.83
Taxes Income Tax -3.69M Effective Tax Rate 16.61%
Stock Price Statistics The stock price has increased by 42.24% in the
last 52 weeks. The beta is 0.61, so ANI Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.61 52-Week Price Change 42.24% 50-Day Moving Average 64.93 200-Day Moving Average 61.7 Relative Strength Index (RSI) 80.98 Average Volume (20 Days) 364,153
Income Statement In the last 12 months, ANI Pharmaceuticals had revenue of 614.38M
and earned -18.52M
in profits. Earnings per share was -0.87.
Revenue 614.38M Gross Profit 364.17M Operating Income 584K Net Income -18.52M EBITDA 79.15M EBIT -4.61M Earnings Per Share (EPS) -0.87
Full Income Statement Balance Sheet The company has 144.86M in cash and 624.09M in
debt, giving a net cash position of -479.23M.
Cash & Cash Equivalents 144.86M Total Debt 624.09M Net Cash -479.23M Retained Earnings -100.28M Total Assets 1.29B Working Capital 334.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 64.02M
and capital expenditures -16.95M, giving a free cash flow of 47.06M.
Operating Cash Flow 64.02M Capital Expenditures -16.95M Free Cash Flow 47.06M FCF Per Share 2.44
Full Cash Flow Statement Margins Gross margin is 59.27%, with operating and profit margins of 0.1% and -3.01%.
Gross Margin 59.27% Operating Margin 0.1% Pretax Margin -3.62% Profit Margin -3.01% EBITDA Margin 12.88% EBIT Margin 0.1% FCF Margin 7.66%
Dividends & Yields ANIP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ANIP is $83,
which is -2.2% lower than the current price. The consensus rating is "Buy".
Price Target $83 Price Target Difference -2.2% Analyst Consensus Buy Analyst Count 8
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 18, 2013. It was a
backward
split with a ratio of 1:6.
Last Split Date Jul 18, 2013 Split Type backward Split Ratio 1:6
Scores Altman Z-Score 1.99 Piotroski F-Score 3
